189 related articles for article (PubMed ID: 28032381)
1. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
[TBL] [Abstract][Full Text] [Related]
2. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.
Giorgi Rossi P; Grazzini G; Anti M; Baiocchi D; Barca A; Bellardini P; Brezzi S; Camilloni L; Falini P; Maccallini V; Mantellini P; Romeo D; Rubeca T; Venditti MA
J Med Screen; 2011; 18(3):121-7. PubMed ID: 22045820
[TBL] [Abstract][Full Text] [Related]
3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
4. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
5. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
6. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
Cole SR; Young GP; Byrne D; Guy JR; Morcom J
J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Gut; 2015 Feb; 64(2):282-91. PubMed ID: 24812001
[TBL] [Abstract][Full Text] [Related]
8. An advance notification letter increases participation in colorectal cancer screening.
Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
[TBL] [Abstract][Full Text] [Related]
9. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.
Steele RJ; McClements PL; Libby G; Carey FA; Fraser CG
Colorectal Dis; 2014 Jan; 16(1):28-32. PubMed ID: 24034143
[TBL] [Abstract][Full Text] [Related]
10. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
[TBL] [Abstract][Full Text] [Related]
11. A comparison of different strategies used to invite subjects with a positive faecal occult blood test to a colonoscopy assessment. A randomised controlled trial in population-based screening programmes.
Zorzi M; Giorgi Rossi P; Cogo C; Falcini F; Giorgi D; Grazzini G; Mariotti L; Matarese V; Soppelsa F; Senore C; Ferro A;
Prev Med; 2014 Aug; 65():70-6. PubMed ID: 24811759
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening.
Steele RJ; Kostourou I; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser C
BMJ; 2010 Oct; 341():c5531. PubMed ID: 20980376
[TBL] [Abstract][Full Text] [Related]
13. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
[TBL] [Abstract][Full Text] [Related]
14. Participation rates for organized colorectal cancer screening programmes: an international comparison.
Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
[TBL] [Abstract][Full Text] [Related]
15. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
16. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
[TBL] [Abstract][Full Text] [Related]
17. Ambient temperature and FIT performance in the Emilia-Romagna colorectal cancer screening programme.
De Girolamo G; Goldoni CA; Corradini R; Giuliani O; Falcini F; Sassoli De'Bianchi P; Naldoni C; Zauli Sajani S
J Med Screen; 2016 Dec; 23(4):186-191. PubMed ID: 27125499
[TBL] [Abstract][Full Text] [Related]
18. The effect of gender-specific invitation letters on utilization of colorectal cancer screening.
Zhan T; Hielscher T; Eckardt M; Giese T; Schäfer C; Riemann JF; Ebert MP; Belle S
Z Gastroenterol; 2019 Sep; 57(9):1051-1058. PubMed ID: 31525797
[TBL] [Abstract][Full Text] [Related]
19. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
[TBL] [Abstract][Full Text] [Related]
20. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]